Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 3561-3580 of 3,895 trials

Occipital Nerve Stimulation in the Treatment of Migraine

NCT01855672

The objective of this proof-of-concept study is to generate initial safety and effectiveness data for the neuro-modulation stimulation (NMS) E-Box in patients with chronic migraine in an acute setting. The results of this study will determine if further development of this device in a larger study is warranted.

Migraine

Ethicon, Inc.1 participantsStarted Apr 2013

Newington, New Hampshire, United States • New York, New York, United States • Cincinnati, Ohio, United States +1 more locations

WITHDRAWNPhase 2< 1 mile

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00085345

RATIONALE: Drugs used in chemotherapy, such as melphalan, arsenic trioxide, and ascorbic acid, work in different ways to stop cancer cells from dividing so they stop growing or die. Arsenic trioxide and ascorbic acid may also help melphalan kill more cancer cells by making them more sensitive to the drugs. PURPOSE: This phase II trial is studying how well giving melphalan together with arsenic trioxide and ascorbic acid works in treating patients with relapsed or refractory multiple myeloma.

Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm

Oncotherapeutics

Glendale, Arizona, United States • Bakersfield, California, United States • Campbell, California, United States +16 more locations

Occipital Nerve Stimulation in the Treatment of Migraine

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Rheumatoid Arthritis Trials in Other Cities

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Immunotoxin Therapy in Treating Patients With Malignant Glioma

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Shingles Prevention Study

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Other Conditions in Philadelphia